文献速递心力衰竭与心肌病血脂与心血管预防

抑制胰岛素介导的β2肾上腺素能受体激活可预防糖尿病相关心脏功能障碍

Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction.
PubMed 文献 · Circulation · 2016-11-04

研究在高脂饮食诱导的肥胖和糖尿病小鼠模型中探索高胰岛素血症导致心脏功能障碍的机制。高脂饮食选择性增加小鼠心脏磷酸二酯酶4D(PDE4D)表达,并降低受磷蛋白的蛋白激酶A磷酸化,导致收缩和舒张功能障碍;糖尿病患者心脏中PDE4D表达也升高。该过程由胰岛素受体、胰岛素受体底物及GRK2和β-arrestin2依赖的β2肾上腺素能受体(β2AR)-细胞外调节蛋白激酶信号通路转激活介导;药物抑制β2AR或GRK2,或遗传删除β2AR或β-arrestin2,均可减轻胰岛素诱导的细胞外调节蛋白激酶磷酸化和PDE4D诱导,预防糖尿病相关收缩功能障碍。

要点

  • 高脂饮食小鼠心脏PDE4D表达选择性增加,与收缩和舒张功能障碍相关。
  • 糖尿病患者心脏中PDE4D表达也升高。
  • 抑制β2AR或GRK2可预防糖尿病相关心脏收缩功能障碍。

核心结论

  • 高胰岛素血症通过增加PDE4D表达促进心力衰竭,β2AR或GRK2是预防或治疗2型糖尿病心力衰竭的潜在靶点。

研究设计与样本

  • 研究使用高脂饮食喂养诱导野生型小鼠或缺乏β2AR或β-arrestin2的小鼠发生肥胖和糖尿病。
  • 高脂饮食喂养的野生型小鼠接受β受体阻滞剂卡维地洛或GRK2抑制剂治疗。
  • 研究检测了信号传导和心脏收缩功能。

主要发现

  • 高脂饮食选择性增加小鼠心脏PDE4D表达,并降低受磷蛋白的蛋白激酶A磷酸化,导致收缩和舒张功能障碍。
  • 糖尿病患者心脏中PDE4D表达也升高。
  • PDE4D表达诱导由胰岛素受体、胰岛素受体底物及GRK2和β-arrestin2依赖的β2AR-细胞外调节蛋白激酶信号级联转激活介导。
  • 药物抑制β2AR或GRK2,或遗传删除β2AR或β-arrestin2,均显著减轻胰岛素诱导的细胞外调节蛋白激酶磷酸化和PDE4D诱导,预防糖尿病相关收缩功能障碍。

临床怎么用

  • β2AR或GRK2可能作为预防或治疗2型糖尿病受试者心力衰竭的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Type 2 diabetes mellitus (DM) and obesity independently increase the risk of heart failure by incompletely understood mechanisms. We propose that hyperinsulinemia might promote adverse consequences in the hearts of subjects with type-2 DM and obesity. METHODS: High-fat diet feeding was used to induce obesity and DM in wild-type mice or mice lacking β2-adrenergic receptor (β2AR) or β-arrestin2. Wild-type mice fed with high-fat diet were treated with a β-blocker carvedilol or a GRK2 (G-protein-coupled receptor kinase 2) inhibitor. We examined signaling and cardiac contractile function. RESULTS: High-fat diet feeding selectively increases the expression of phosphodiesterase 4D (PDE4D) in mouse hearts, in concert with reduced protein kinase A phosphorylation of phospholamban, which contributes to systolic and diastolic dysfunction. The expression of PDE4D is also elevated in human hearts with DM. The induction of PDE4D expression is mediated by an insulin receptor, insulin receptor substrate, and GRK2 and β-arrestin2-dependent transactivation of a β2AR-extracellular regulated protein kinase signaling cascade. Thus, pharmacological inhibition of β2AR or GRK2, or genetic deletion of β2AR or β-arrestin2, all significantly attenuate insulin-induced phosphorylation of extracellular regulated protein kinase and PDE4D induction to prevent DM-related contractile dysfunction. CONCLUSIONS: These studies elucidate a novel mechanism by which hyperinsulinemia contributes to heart failure by increasing PDE4D expression and identify β2AR or GRK2 as plausible therapeutic targets for preventing or treating heart failure in subjects with type 2 DM.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Wang Q, Liu Y, Fu Q, et al. Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction. Circulation. 2016. PMID: 27815373. doi:10.1161/CIRCULATIONAHA.116.022281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。